MYLK2 and liver cancer: To identify pharmacological means to alter 2D cell migration in liver cancer, we targeted key regulators of the Rho GTPases, including calcium signaling, Rac1, PAK4, LIMK1, MLCK, and actomyosin contractility (Fig. 3a).